Skip to content

ECPR for Refractory Out-Of-Hospital Cardiac Arrest

Extracorporeal CPR for Refractory Out-of-Hospital Cardiac Arrest (EROCA)

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03065647
Acronym
EROCA
Enrollment
15
Registered
2017-02-28
Start date
2017-05-01
Completion date
2020-03-05
Last updated
2021-06-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest, Cardiopulmonary Arrest, Cardiopulmonary Resuscitation, CPR, Death, Sudden, Cardiac, Extracorporeal Cardiopulmonary Resuscitation, Extracorporeal Membrane Oxygenation, Heart Arrest, Sudden Cardiac Arrest

Keywords

Out-of-hospital cardiac arrest, Cardiac Arrest, Heart Arrest, Sudden Cardiac Arrest, Cardiopulmonary Resuscitation, Extracorporeal Cardiopulmonary Resuscitation, Extracorporeal Membrane Oxygenation, CPR, ECPR, ECMO, Emergency Medical Services, EMS, OHCA

Brief summary

In the U.S. alone, over 300,000 people per year have sudden out-of-hospital cardiac arrest (OHCA), and less than 1 out of 10 survive. The current standard practice for treating OHCA is to perform cardiopulmonary resuscitation (CPR) and Advanced Cardiovascular Life Support (ACLS) at the scene until either the heart is restarted or resuscitation efforts are considered hopeless and discontinued. An alternative strategy for those with refractory OHCA is expedited transport with ongoing mechanical CPR to an Emergency Department capable of performing extracorporeal cardiopulmonary resuscitation (ECPR). The purpose of study is to test if this strategy is feasible and beneficial.

Detailed description

Out-of-hospital sudden cardiac arrest (OHCA) is a life-threatening condition in which the heart suddenly stops beating and there is no blood flow to the body. If cardiac arrest is not treated immediately, it causes sudden death. In the U.S. alone, over 300,000 people per year have OHCA, and less than 1 out of 10 survive. Therefore, it is important to study new ways of treating cardiac arrest patients in order to improve survival. The current standard practice for treating OHCA is to perform CPR and Advanced Cardiovascular Life Support (ACLS) at the scene until either the heart is restarted or resuscitation efforts are considered hopeless and discontinued. This practice is supported by the fact that all currently proven CPR therapies can be delivered by paramedics in the field. However, promising new strategies have emerged that are more feasible to initiate in the hospital. One such strategy is extracorporeal cardiopulmonary resuscitation (ECPR). ECPR requires placement of catheters in large blood vessels and connected to a machine to take over the work of the heart and lungs. This purpose of this study is to examine the feasibility and potential benefit of expedited transport with ongoing mechanical CPR for patients with refractory OHCA patients to an Emergency Department capable of initiating ECPR. FDA approved this study as a staged feasibility study to enroll 15 participants and submit data prior to enrolling the second 15 participants. After enrolling 15 participants, the PI chose not to pursue an amendment to enroll additional participants due to slow accrual and research restrictions related to COVID.

Interventions

DEVICEExpedited Transport With Mechanical CPR

Patients with OHCA refractory to initial BLS and ACLS will be transported by EMS with ongoing mechanical CPR and ACLS to an emergency department capable of initiating ECPR.

Sponsors

National Heart, Lung, and Blood Institute (NHLBI)
CollaboratorNIH
Food and Drug Administration (FDA)
CollaboratorFED
Physio-Control
CollaboratorINDUSTRY
University of Michigan
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* OHCA of presumed non-traumatic etiology requiring CPR * Predicted arrival time at ECPR-capable hospital within timeframe specified * Witnessed arrest or initial shockable rhythm (VT or VF) * Persistent cardiac arrest after initial cardiac rhythm analysis and shock (if shock is indicated)

Exclusion criteria

* Sustained return of spontaneous circulation (ROSC) * Advanced directive indicating do not attempt resuscitation (DNAR) or do not intubate (DNI) * Preexisting evidence of opting out of study * Prisoner * Pregnant (obvious or known) * ECPR capable ED is not at the destination hospital as determined by EMS * Legally authorized representative (LAR) or family member aware of study and refuses study participation at the scene

Design outcomes

Primary

MeasureTime frameDescription
Emergency Department Arrivals Under 30 MinutesMeasured within one hour cardiac arrest onsetProportion of patients with emergency department (ED) arrival less than or equal to 30 minutes from 911 call (or cardiac arrest onset if witnessed by EMS personnel).
ECPR Initiations Under 30 MinutesMeasured within 2 hours of cardiac arrest onsetProportion of ECPR eligible patients with ECPR flow initiated less than or equal to 30 minutes from ED arrival

Other

MeasureTime frameDescription
Neuropsychological Outcome Battery: NIH ToolboxAt time of hospital discharge (an average of 7 days) and 90 days after cardiac arrestThe NIH toolbox includes cognitive testing and can be administered using an iPad
Functional Neurological Outcome: CPCAt time of hospital discharge (an average of 7 days) and 90 days after cardiac arrestCerebral Performance Category score is widely used in cardiac arrest research to assess neurologic outcome
Safety: Composite Prevalence of 6 Specified Adverse EventsAt time of hospital discharge (an average of 7 days) and 90 days after cardiac arrestComposite safety endpoint of hemorrhage requiring blood transfusion, vessel damage requiring vascular procedure or leading to occlusion, venous/arterial thromboembolism, stroke, renal failure, and infection.
Neuro Quality of Life: Neuro QoL90 days after cardiac arrestQuality of Life in Neurological Disorders is a measurement system that evaluates and monitors the physical, mental, and social effects experienced by adults living with neurological conditions.
Functional Neurological Outcome: mRSAt time of hospital discharge (an average of 7 days) and 90 days after cardiac arrestmodified Rankin Score commonly used for measuring the degree of disability or dependence in the daily activities of people who have suffered a neurological disability.

Countries

United States

Participant flow

Participants by arm

ArmCount
Standard Care
Basic Life Support (BLS) and Advanced Cardiovascular Life Support (ACLS) by Emergency Medical Services (EMS) per existing EMS protocols at the scene of the cardiac arrest.
3
Expedited Transport
Intervention: Expedited Transport with Mechanical CPR. After initial Basic Life Support (BLS) and Advanced Cardiovascular Life Support (ACLS) by Emergency Medical Services (EMS) per existing EMS protocols, patients with refractory cardiac arrest are transported to an ECPR capable emergency department with ongoing mechanical CPR and ACLS for possible initiation of extracorporeal cardiopulmonary resuscitation (ECPR). Expedited Transport With Mechanical CPR: Patients with OHCA refractory to initial BLS and ACLS will be transported by EMS with ongoing mechanical CPR and ACLS to an emergency department capable of initiating ECPR.
12
Total15

Baseline characteristics

CharacteristicStandard CareExpedited TransportTotal
Age, Continuous61 years
STANDARD_DEVIATION 3
62 years
STANDARD_DEVIATION 8
62 years
STANDARD_DEVIATION 7
Bystander CPR3 Participants10 Participants13 Participants
Cardiac Arrest Locaion
Home
2 participants10 participants12 participants
Cardiac Arrest Locaion
Public Location
1 participants2 participants3 participants
Initial cardiac rythm
Ventricular fibrilation
3 Participants5 Participants8 Participants
Initial cardiac rythm
Witnessed asystole
0 Participants3 Participants3 Participants
Initial cardiac rythm
Witnessed pulseless electrical activity (PEA)
0 Participants4 Participants4 Participants
Race (NIH/OMB)
American Indian or Alaska Native
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Asian
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Black or African American
0 Participants1 Participants1 Participants
Race (NIH/OMB)
More than one race
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
0 Participants0 Participants0 Participants
Race (NIH/OMB)
Unknown or Not Reported
0 Participants2 Participants2 Participants
Race (NIH/OMB)
White
3 Participants9 Participants12 Participants
Sex: Female, Male
Female
1 Participants4 Participants5 Participants
Sex: Female, Male
Male
2 Participants8 Participants10 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
2 / 312 / 12
other
Total, other adverse events
0 / 30 / 12
serious
Total, serious adverse events
2 / 36 / 12

Outcome results

Primary

ECPR Initiations Under 30 Minutes

Proportion of ECPR eligible patients with ECPR flow initiated less than or equal to 30 minutes from ED arrival

Time frame: Measured within 2 hours of cardiac arrest onset

Population: Analysis includes participants eligible for ECPR.

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Expedited TransportECPR Initiations Under 30 Minutes3 Participants
Primary

Emergency Department Arrivals Under 30 Minutes

Proportion of patients with emergency department (ED) arrival less than or equal to 30 minutes from 911 call (or cardiac arrest onset if witnessed by EMS personnel).

Time frame: Measured within one hour cardiac arrest onset

Population: Standard care participants received EMS protocols at the scene, and thus were not included in this analysis

ArmMeasureValue (COUNT_OF_PARTICIPANTS)
Expedited TransportEmergency Department Arrivals Under 30 Minutes5 Participants
Other Pre-specified

Functional Neurological Outcome: CPC

Cerebral Performance Category score is widely used in cardiac arrest research to assess neurologic outcome

Time frame: At time of hospital discharge (an average of 7 days) and 90 days after cardiac arrest

Other Pre-specified

Functional Neurological Outcome: mRS

modified Rankin Score commonly used for measuring the degree of disability or dependence in the daily activities of people who have suffered a neurological disability.

Time frame: At time of hospital discharge (an average of 7 days) and 90 days after cardiac arrest

Other Pre-specified

Neuropsychological Outcome Battery: NIH Toolbox

The NIH toolbox includes cognitive testing and can be administered using an iPad

Time frame: At time of hospital discharge (an average of 7 days) and 90 days after cardiac arrest

Other Pre-specified

Neuro Quality of Life: Neuro QoL

Quality of Life in Neurological Disorders is a measurement system that evaluates and monitors the physical, mental, and social effects experienced by adults living with neurological conditions.

Time frame: 90 days after cardiac arrest

Other Pre-specified

Safety: Composite Prevalence of 6 Specified Adverse Events

Composite safety endpoint of hemorrhage requiring blood transfusion, vessel damage requiring vascular procedure or leading to occlusion, venous/arterial thromboembolism, stroke, renal failure, and infection.

Time frame: At time of hospital discharge (an average of 7 days) and 90 days after cardiac arrest

Source: ClinicalTrials.gov · Data processed: Feb 25, 2026